London Daily

Focus on the big picture.
Thursday, Nov 13, 2025

Ignore the pessimism: Covid vaccines are quietly prevailing

Ignore the pessimism: Covid vaccines are quietly prevailing

Nightmare scenarios involving deadly new variants are making us all too gloomy – but there’s a scientific case for optimism
It can be quite easy, reading the press, to believe that the pandemic will never end. Even when good news about vaccines started to arrive in the autumn, this grim narrative managed to harden. In the past month, you could read “five reasons that herd immunity is probably impossible”, even with mass vaccination; breathless reports about yet-uncharacterised but potentially ruinous variants, such as the “double mutant” variant in India, or two concerning variants potentially swapping mutations and teaming up in a “nightmare scenario” in California; get ready, some analysts said, for the “permanent pandemic”.

Among many people I know, a sort of low-grade doom has set in. They think the vaccines are a mere sliver of hope, only holding back the virus for a short time before being worn down by a rush of ever-cleverer variants that will slosh around us, perhaps for ever. Things might briefly get better, they believe, but only by a little, and even that is tenuous.

However despite such dark talk, and the potential difficulties along the way of vaccine rollout, I still remain optimistic. Since about the midway point of last year I have believed that extremely potent vaccines are going to end the pandemic. They’ll do so by either driving the disease down to near-extinction, or so constraining its force and spread that it becomes a manageable concern, like measles or mumps. I actually think this will happen fairly soon, as long as we get everyone – the whole world, not just the rich – vaccinated.

The scientific case for optimism is straightforward. The vaccines we have are beyond very good, they’re among the most effective ever created. They appear to be potent in real-life situations, and results so far show that protection is long-lasting. Crucially, new results in the US show that the mRNA vaccines used there effectively prevented coronavirus infections – not just serious symptoms – in results similar to those previously reported by a UK-based study. And another study in the UK suggested that vaccinated groups were less likely to spread coronavirus infection overall. This is exactly what we need to choke out the pandemic: vaccines that don’t just protect, but actually halt the virus infecting people and spreading.

When it comes to variants, it is clear that some are more infectious, and some are more deadly. But their interaction with vaccines isn’t yet clear. Some lab-based results show that certain viral mutations may make some immune responses less potent. And one study suggested the Oxford/AstraZeneca vaccine might be less potent against the South African variant. But the majority of scientists believe that vaccines have so far held the line, and will continue to do so. If variants continue to make small advances, vaccines can be updated. A doomsday strain may be possible, but exceedingly hard to predict. Evolution isn’t an on-demand miracle worker for viral supremacy; even over decades most viruses don’t escape vaccine protection.

The stories suggesting a dismal and dangerous future aren’t wrong, per se. There is clearly a long way to go in ending the pandemic. A few pieces are sensationalistic (some scientists have taken to calling the rolling panics accompanying each new mutation “scariants” or “mutant porn”), but most are good-faith reporting of what experts say, or attempts to tune public discourse away from naive false hopes (most articles) or, more rarely, away from miserable and abject doom (this article).

What they do, in aggregate, is try to describe the future in a time of incredible uncertainty. And, as a rule, we’re quite bad at dealing with uncertainty. During the pandemic the public sphere sometimes appears to be in the middle of a full-blown epistemic crisis over this, with wildly different claims about what “the science” portends. The truth is that the science we see now is itself uncertain. It’s not a process of years-long studies that provide near-definitive answers. We’re all mucking about behind the scientific curtain, looking at science as it’s being done; at inferences and hypotheses; incomplete and ongoing studies. Often, what is parsed publicly these days as “science” is just informed guesses by experts.

This can pile up and become paralysing. Especially since the pandemic itself exploded our horizon for negative possibilities. It seems like each day there there are a thousand new paths the future might take, and no way to know how solid each might actually be. Even more, as each piece of good news comes freighted with new caveats and doomsday scenarios, it can feel like things are nearly as uncertain now as they were at the beginning of the crisis. Like everything we know could suddenly and radically shift, the same way it did last March.

That isn’t the case. There are two massive and opposing fronts of uncertainty facing us. We don’t yet know for certain if vaccines will effectively halt transmission. On this, we have some indication that it looks good, and conclusive answers are coming. And we don’t know what (terrible) variants might yet emerge. But even though that unknown seems massive, variants aren’t some immunological antimatter destined to suddenly and totally vaporise the vaccines.

Seen this way, the possibilities don’t look so grim. Early in the pandemic we had nothing, the timeline for vaccines and whether they would work was uncertain, the outside chance was that they would take years, or they would fail. The horizon was the virus, and just how bad it could get. Now the vaccines are the horizon, and it is the virus that has only the outside chance to delay or disrupt our path there.
Newsletter

Related Articles

0:00
0:00
Close
UK Upholds Firm Rules on Stablecoins to Shield Financial System
Brussels Divided as UK-EU Reset Stalls Over Budget Access
Prince Harry’s Remembrance Day Essay Expresses Strong Regret at Leaving Britain
UK Unemployment Hits 5% as Wage Growth Slows, Paving Way for Bank of England Rate Cut
Starmer Warns of Resurgent Racism in UK Politics as He Vows Child-Poverty Reforms
UK Grocery Inflation Slows to 4.7% as Supermarkets Launch Pre-Christmas Promotions
UK Government Backs the BBC amid Editing Scandal and Trump Threat of Legal Action
UK Assessment Mis-Estimated Fallout From Palestine Action Ban, Records Reveal
UK Halts Intelligence Sharing with US Amid Lethal Boat-Strike Concerns
King Charles III Leads Britain in Remembrance Sunday Tribute to War Dead
UK Retail Sales Growth Slows as Households Hold Back Ahead of Black Friday and Budget
Shell Pulls Out of Two UK Floating Wind Projects Amid Renewables Retreat
Viagogo Hit With £15 Million Tax Bill After HMRC Transfer-Pricing Inquiry
Jaguar Land Rover Cyberattack Pinches UK GDP, Bank of England Says
UK and Germany Sound Alarm on Russian-Satellite Threat to Critical Infrastructure
Former Prince Andrew Faces U.S. Congressional Request for Testimony Amid Brexit of Royal Title
BBC Director-General Tim Davie and News CEO Deborah Turness Resign Amid Editing Controversy
Tom Cruise Arrives by Helicopter at UK Scientology Fundraiser Amid Local Protests
Prince Andrew and Sarah Ferguson Face Fresh UK Probes Amid Royal Fallout
Mothers Link Teen Suicides to AI Chatbots in Growing Legal Battle
UK Government to Mirror Denmark’s Tough Immigration Framework in Major Policy Shift
UK Government Turns to Denmark-Style Immigration Reforms to Overhaul Border Rules
UK Chancellor Warned Against Cutting Insulation Funding as Budget Looms
UK Tenant Complaints Hit Record Levels as Rental Sector Faces Mounting Pressure
Apple to Pay Google About One Billion Dollars Annually for Gemini AI to Power Next-Generation Siri
UK Signals Major Shift as Nuclear Arms Race Looms
BBC’s « Celebrity Traitors UK » Finale Breaks Records with 11.1 Million Viewers
UK Spy Case Collapse Highlights Implications for UK-Taiwan Strategic Alignment
On the Road to the Oscars? Meghan Markle to Star in a New Film
A Vote Worth a Trillion Dollars: Elon Musk’s Defining Day
AI Researchers Claim Human-Level General Intelligence Is Already Here
President Donald Trump Challenges Nigeria with Military Options Over Alleged Christian Killings
Nancy Pelosi Finally Announces She Will Not Seek Re-Election, Signalling End of Long Congressional Career
UK Pre-Budget Blues and Rate-Cut Concerns Pile Pressure on Pound
ITV Warns of Nine-Per-Cent Drop in Q4 Advertising Revenue Amid Budget Uncertainty
National Grid Posts Slightly Stronger-Than-Expected Half-Year Profit as Regulatory Investments Drive Growth
UK Business Lobby Urges Reeves to Break Tax Pledges and Build Fiscal Headroom
UK to Launch Consultation on Stablecoin Regulation on November 10
UK Savers Rush to Withdraw Pension Cash Ahead of Budget Amid Tax-Change Fears
Massive Spoilers Emerge from MAFS UK 2025: Couple Swaps, Dating App Leaks and Reunion Bombshells
Kurdish-led Crime Network Operates UK Mini-Marts to Exploit Migrants and Sell Illicit Goods
UK Income Tax Hike Could Trigger £1 Billion Cut to Scotland’s Budget, Warns Finance Secretary
Tommy Robinson Acquitted of Terror-related Charge After Phone PIN Dispute
Boris Johnson Condemns Western Support for Hamas at Jewish Community Conference
HII Welcomes UK’s Westley Group to Strengthen AUKUS Submarine Supply Chain
Tragedy in Serbia: Coach Mladen Žižović Collapses During Match and Dies at 44
Diplo Says He Dated Katy Perry — and Justin Trudeau
Dick Cheney, Former U.S. Vice President, Dies at 84
Trump Calls Title Removal of Andrew ‘Tragic Situation’ Amid Royal Fallout
UK Bonds Rally as Chancellor Reeves Briefs Markets Ahead of November Budget
×